Results from the SOUL Trial: The Cardiologists' Perspective
Update: 2025-11-28
Description
Watch the full video on YouTube to explore the cardiologistās perspective on one of the most important cardiovascular outcomes trials in recent years.
In this episode, Vivienne Parry speaks with Dr Matthew Cavender (University of North Carolina) about the SOUL trial, which evaluated the cardiovascular impact of oral semaglutide in more than 8,000 people with type 2 diabetes.
They discuss:
- How oral semaglutide reduced major cardiovascular events by 14%
- Why an oral GLP-1 receptor agonist may broaden access and adherence
- Implications for diabetologist's, cardiologists and primary care
- How team-based care can improve uptake of evidence-based therapies
- What the latest ESC guidelines mean for future prescribing
š§ Listen now for a clear, accessible breakdown of a landmark study reshaping diabetes and cardiovascular risk management. To learn more about our expert speaker:
CommentsĀ
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
